Pain — Impact of Hypnosis on Pain Management During Dialysis on Patients Suffering From Arterial Disease
Citation(s)
Allen D, Wainwright M, Hutchinson T 'Non-compliance' as illness management: Hemodialysis patients' descriptions of adversarial patient-clinician interactions. Soc Sci Med. 2011 Jul;73(1):129-34. doi: 10.1016/j.socscimed.2011.05.018. Epub 2011 May 27.
Bioy A Traiter la douleur par l'hypnose. Cahier scientifique AFIDTN 2010 Dec, N°93 : 13-15.
Chan YM, Zalilah MS, Hii SZ Determinants of compliance behaviours among patients undergoing hemodialysis in Malaysia. PLoS One. 2012;7(8):e41362. doi: 10.1371/journal.pone.0041362. Epub 2012 Aug 3.
Chauveau S " Malades ou consommateurs ? La consommation de médicaments en France (second XXe siècle) ", Au nom du consommateur. Consommation et politique en Europe et aux Etats-Unis au XXe siècle, sous la direction de Marie Chessel, Alain Chatriot et Matthew Hilton, Paris, La Découverte, 2005, p. 182-198.
Dillworth T, Mendoza ME, Jensen MP Neurophysiology of pain and hypnosis for chronic pain. Transl Behav Med. 2012 Mar;2(1):65-72. doi: 10.1007/s13142-011-0084-5.
Editorial Comfortably numb. The Association of Anaesthetists of Great Britain and Ireland 2013 ;Vol 68 : 896-898.
Elkins G, Jensen MP, Patterson DR Hypnotherapy for the management of chronic pain. Int J Clin Exp Hypn. 2007 Jul;55(3):275-87. Review.
Haute Autorité de Santé [Management of chronic lower-limb obliterative atherosclerosis (indications for drug treatment, revascularisation and physiotherapy). Professional Guidelines Department - April 2006]. Ann Dermatol Venereol. 2007 Feb;134(2):199-206. French.
Howard J Do Bach flower remedies have a role to play in pain control? A critical analysis investigating therapeutic value beyond the placebo effect, and the potential of Bach flower remedies as a psychological method of pain relief. Complement Ther Clin Pract. 2007 Aug;13(3):174-83. Epub 2007 Apr 23.
Iserson KV An hypnotic suggestion: review of hypnosis for clinical emergency care. J Emerg Med. 2014 Apr;46(4):588-96. doi: 10.1016/j.jemermed.2013.09.024. Epub 2014 Jan 25. Review.
Jensen M, Patterson DR Hypnotic treatment of chronic pain. J Behav Med. 2006 Feb;29(1):95-124. Epub 2006 Jan 11.
Kekecs Z, Varga K Positive suggestion techniques in somatic medicine: A review of the empirical studies. Interv Med Appl Sci. 2013 Sep;5(3):101-11. doi: 10.1556/IMAS.5.2013.3.2. Epub 2013 Sep 16.
Murtagh FE, Addington-Hall J, Higginson IJ The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007 Jan;14(1):82-99. Review.
Rainville P Neurophenomenologie des etats et des contenus de conscience dans l'hypnose et l'analgesie hypnotique. Théologiques, Université de Montréal, Montréal, Canada. 2004, vol. 12, no1-2, pp. 15-38.
Rüger Prise en charge de la douleur dans l'ischémie chronique des membres inferieurs Pain 2008 Septembre 30 139 (1) 2 : 201-208
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
